Freedom From Diabetes Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-06-2024
- Paid Up Capital ₹ 0.10 M
as on 17-06-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -4.25%
(FY 2023)
- Profit 7.37%
(FY 2023)
- Ebitda -9.18%
(FY 2023)
- Net Worth 9.71%
(FY 2023)
- Total Assets 8.14%
(FY 2023)
About Freedom From Diabetes Research Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sharda Tripathi and Pramod Tripathi serve as directors at the Company.
- CIN/LLPIN
U74995PN2016NPL165507
- Company No.
165507
- Company Classification
Private Not For Profit Company
- Incorporation Date
14 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Freedom From Diabetes Research Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharda Tripathi  | Director | 16-Feb-2023 | Current |
| Pramod Tripathi | Director | 14-Jul-2016 | Current |
Financial Performance of Freedom From Diabetes Research Foundation.
Freedom From Diabetes Research Foundation, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.25% decrease. The company also saw a slight improvement in profitability, with a 7.37% increase in profit. The company's net worth moved up by a moderate rise of 9.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Freedom From Diabetes Research Foundation?
In 2023, Freedom From Diabetes Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr Pramod Tripathi's Freedom From Diabetes LlpActive 1 year 1 monthSharda Tripathi and Pramod Tripathi are mutual person
Dr. Pramod Tripathi's Health Technology Private LimitedActive 2 years 7 monthsSharda Tripathi and Pramod Tripathi are mutual person
- Dr Pramod Tripathi's Freedom From Lifestyle Disorders Private LimitedActive 2 years 8 months
Sharda Tripathi and Pramod Tripathi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Freedom From Diabetes Research Foundation?
Freedom From Diabetes Research Foundation has a workforce of 6 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Freedom From Diabetes Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Freedom From Diabetes Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
